
Webinar: Antibodies to watch in 2025
Webinars @BioTechniques posted 2 weeks ago in Microbiology & molecular biology Email OpportunityOpportunity Description
In this webinar, brought to you by The Antibody Society (MA, USA), in association with the journal mAbs, Drs. Crescioli and Reichert discuss the recent trends in antibody therapeutics development presented in the annual mAbs publication detailing the ‘antibodies to watch’ for the upcoming year.
They briefly review approvals from 2024 and product candidates with recent marketing applications under consideration, providing insight into the factors influencing the emerging trends in this field, before exploring the investigational antibody therapeutics forecast to enter regulatory review by the end of 2025. These product candidates include numerous innovative bispecific antibodies and antibody-drug conjugates. They also discuss clinical phase transition and overall approval success rates for antibody therapeutics, which are crucial to the biopharmaceutical industry.
Additional Information on the opportunity
-
Opportunity ID 9489